These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37000890)

  • 1. Acceptability and perceived barriers to reactive focal mass drug administration in the context of a malaria elimination program in Magude district, Southern Mozambique: A qualitative study.
    Cuinhane CE; Galatas B; Lopez JM; Djive H; Nhantumbo H; Murato I; Saúte F; Aide P; Munguambe K; Torres N
    PLoS One; 2023; 18(3):e0283160. PubMed ID: 37000890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: A mixed methods study.
    Galatas B; Nhantumbo H; Soares R; Djive H; Murato I; Simone W; Macete E; Rabinovich NR; Alonso P; Candrinho B; Saúte F; Aide P; Munguambe K
    PLoS One; 2021; 16(3):e0249080. PubMed ID: 33755685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "We were afraid of the lion that has roared next to us"; community response to reactive focal mass drug administration for malaria in Eswatini (formerly Swaziland).
    Baltzell KA; Maglior A; Bangu K; Mngadi N; Prach LM; Whittemore B; Ntshalintshali N; Saini M; Dlamini N; Kunene S; Hsiang MS
    Malar J; 2019 Jul; 18(1):238. PubMed ID: 31307494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining community perceptions of malaria to inform elimination efforts in Southern Mozambique: a qualitative study.
    Portugaliza HP; Galatas B; Nhantumbo H; Djive H; Murato I; Saúte F; Aide P; Pell C; Munguambe K
    Malar J; 2019 Jul; 18(1):232. PubMed ID: 31296238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
    Medzihradsky OF; Kleinschmidt I; Mumbengegwi D; Roberts KW; McCreesh P; Dufour MK; Uusiku P; Katokele S; Bennett A; Smith J; Sturrock H; Prach LM; Ntuku H; Tambo M; Didier B; Greenhouse B; Gani Z; Aerts A; Gosling R; Hsiang MS
    BMJ Open; 2018 Jan; 8(1):e019294. PubMed ID: 29374672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos).
    Adhikari B; Phommasone K; Kommarasy P; Soundala X; Souvanthong P; Pongvongsa T; Henriques G; Newton PN; White NJ; Day NPJ; Dondorp AM; von Seidlein L; Mayxay M; Cheah PY; Pell C
    Malar J; 2018 Jan; 17(1):15. PubMed ID: 29316932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed-methods study in Zambezi region, Namibia.
    Roberts KW; Smith Gueye C; Baltzell K; Ntuku H; McCreesh P; Maglior A; Whittemore B; Uusiku P; Mumbengegwi D; Kleinschmidt I; Gosling R; Hsiang MS
    Malar J; 2021 Mar; 20(1):162. PubMed ID: 33752673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study.
    Galatas B; Saúte F; Martí-Soler H; Guinovart C; Nhamussua L; Simone W; Munguambe H; Hamido C; Montañà J; Muguande O; Maartens F; Luis F; Paaijmans K; Mayor A; Bassat Q; Menéndez C; Macete E; Rabinovich R; Alonso PL; Candrinho B; Aide P
    PLoS Med; 2020 Aug; 17(8):e1003227. PubMed ID: 32797101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community knowledge and acceptance of indoor residual spraying for malaria prevention in Mozambique: a qualitative study.
    Magaço A; Botão C; Nhassengo P; Saide M; Ubisse A; Chicumbe S; Zulliger R
    Malar J; 2019 Jan; 18(1):27. PubMed ID: 30683091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and health community-based surveys to inform a malaria elimination project in Magude district, southern Mozambique.
    Galatas B; Nhacolo A; Marti H; Munguambe H; Jamise E; Guinovart C; Cirera L; Amone F; Macete E; Bassat Q; Rabinovich R; Alonso P; Aide P; Saute F; Sacoor C
    BMJ Open; 2020 May; 10(5):e033985. PubMed ID: 32371510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
    Hsiang MS; Ntuku H; Roberts KW; Dufour MK; Whittemore B; Tambo M; McCreesh P; Medzihradsky OF; Prach LM; Siloka G; Siame N; Gueye CS; Schrubbe L; Wu L; Scott V; Tessema S; Greenhouse B; Erlank E; Koekemoer LL; Sturrock HJW; Mwilima A; Katokele S; Uusiku P; Bennett A; Smith JL; Kleinschmidt I; Mumbengegwi D; Gosling R
    Lancet; 2020 Apr; 395(10233):1361-1373. PubMed ID: 32334702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The social dimensions of community delivery of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria and the Democratic Republic of the Congo.
    Alonso Y; Lusengi W; Manun'Ebo MF; Rasoamananjaranahary AM; Rivontsoa NM; Mucavele E; Torres N; Sacoor C; Okebalama H; Agbor UJ; Nwankwo O; Meremikwu M; Roman E; Pagnoni F; Menéndez C; Munguambe K; Enguita-Fernàndez C
    BMJ Glob Health; 2022 Nov; 7(11):. PubMed ID: 36319032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial.
    Ntuku H; Smith-Gueye C; Scott V; Njau J; Whittemore B; Zelman B; Tambo M; Prach LM; Wu L; Schrubbe L; Kang Dufour MS; Mwilima A; Uusiku P; Sturrock H; Bennett A; Smith J; Kleinschmidt I; Mumbengegwi D; Gosling R; Hsiang M
    BMJ Open; 2022 Jun; 12(6):e049050. PubMed ID: 35738650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What drives community adherence to indoor residual spraying (IRS) against malaria in Manhiça district, rural Mozambique: a qualitative study.
    Munguambe K; Pool R; Montgomery C; Bavo C; Nhacolo A; Fiosse L; Sacoor C; Nhalungo D; Mabunda S; Macete E; Alonso P
    Malar J; 2011 Nov; 10():344. PubMed ID: 22111698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region.
    Pell CL; Adhikari B; Myo Thwin M; Kajeechiwa L; Nosten S; Nosten FH; Sahan KM; Smithuis FM; Nguyen TN; Hien TT; Tripura R; Peto TJ; Sanann N; Nguon C; Pongvongsa T; Phommasone K; Mayxay M; Mukaka M; Peerawaranun P; Kaehler N; Cheah PY; Day NPJ; White NJ; Dondorp AM; von Seidlein L
    PLoS One; 2019; 14(3):e0214280. PubMed ID: 30908523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community facilitators and barriers to a successful implementation of mass drug administration and indoor residual spraying for malaria prevention in Uganda: a qualitative study.
    Wanzira H; Naiga S; Mulebeke R; Bukenya F; Nabukenya M; Omoding O; Echodu D; Yeka A
    Malar J; 2018 Dec; 17(1):474. PubMed ID: 30558632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.
    Fehr A; Nieto-Sanchez C; Muela J; Jaiteh F; Ceesay O; Maneh E; Baldeh D; Achan J; Dabira E; Conteh B; Bunders-Aelen J; Smekens T; Broekhuizen H; D'Alessandro U; Peeters Grietens K
    Malar J; 2021 Apr; 20(1):198. PubMed ID: 33902611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Wherever doctors cannot reach, the sunshine can": overcoming potential barriers to malaria elimination interventions in Haiti.
    Druetz T; Andrinopoulos K; Boulos LM; Boulos M; Noland GS; Desir L; Lemoine JF; Eisele TP
    Malar J; 2018 Oct; 17(1):393. PubMed ID: 30373575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.
    Arnaldo P; Cambe MI; Magaço A; Chicumbe S; Rovira-Vallbona E; Rosanas-Urgell A; Enosse SM
    PLoS One; 2019; 14(1):e0203740. PubMed ID: 30677039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.